BioNeutra Global (TSXV:BGA) ROE % Adjusted to Book Value : 0.00% (As of Sep. 2024)

View and export this data going back to 1999. Start your Free Trial

What is BioNeutra Global ROE % Adjusted to Book Value?

BioNeutra Global's ROE % for the quarter that ended in Sep. 2024 was 0.00%. BioNeutra Global's PB Ratio for the quarter that ended in Sep. 2024 was N/A. BioNeutra Global's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was N/A.

BioNeutra Global ROE % Adjusted to Book Value Historical Data

The historical data trend for BioNeutra Global's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNeutra Global ROE % Adjusted to Book Value Chart

BioNeutra Global Annual Data

Trend

Feb14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-37.11

-11.03

BioNeutra Global Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-	Negative Equity	-	-	-

Competitive Comparison of BioNeutra Global's ROE % Adjusted to Book Value

For the Packaged Foods subindustry, BioNeutra Global's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioNeutra Global's ROE % Adjusted to Book Value Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, BioNeutra Global's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where BioNeutra Global's ROE % Adjusted to Book Value falls into.

BioNeutra Global ROE % Adjusted to Book Value Calculation

BioNeutra Global's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

BioNeutra Global's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

BioNeutra Global ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of BioNeutra Global's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

BioNeutra Global Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioNeutra Global Corp (TSXV:BGA) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

9608 - 25 Avenue NW, Edmonton, AB, CAN, T6N 1J4

Website

http://www.bioneutra.ca

BioNeutra Global Corp is engaged in the research, development, production, and commercialization of food ingredients for neutraceutical, functional and mainstream foods, focusing on oligosaccharides. Its product portfolio provides ingredients for various food systems, that contribute to human nutrition and wellness in functional and healthy foods. Its prime product, VitaFiber IMO, is offered in both powder and syrup form. The company operates in Canada while generating sales revenue from various countries internationally. It has a single industry segment, manufacturing and trading of products. The majority of the revenue is derived from the United States.

Executives

Douglas Alan Horner	Director, Senior Officer
Monica Barclay	Senior Officer

BioNeutra Global Headlines

No Headlines